← back to search

Ying Kong

Nanchang University · CN
Area of research
Cancer Research · Immunology
Research interest
Research focused on Dosing and Peroxisome proliferator-activated receptor, with related work in Ectopic expression, Omics, Tacrolimus. Notable publications include 'tRF/miR-1280 Suppresses Stem Cell–like Cells and Metastasis in Colorectal Cancer', 'Advancements and applications of single-cell multi-omics techniques in cancer research: Unveiling heterogeneity and paving the way for precision therapeutics', and 'Cthrc1 overexpression is an independent prognostic marker in gastric cancer'.
h-index
citations
640
works
16
NIH funding
primary concept
email

Recent publications

CD34 in preeclampsia: The role of endothelial cell pyroptosis and regulation by melatonin via melatonin membrane receptor 1
International Journal of Biological Macromolecules 2025cited by 3position: middledoi
Punicalin ameliorates vascular endothelial cell pyroptosis and dysfunction induced by hyperlipidemia and hyperglycemia through activation of PPARγ
International Immunopharmacology 2025cited by 3position: lastdoi
Role of dexmedetomidine in postoperative cognitive dysfunction and sleep improvement in aged rats by regulating the PI3K/Akt signaling pathway and its mechanism
Brain Research 2025cited by 3position: firstdoi
Acetylation of TIR domains in the TLR4-Mal-MyD88 complex regulates immune responses in sepsis
The EMBO Journal 2024cited by 31position: middledoi
IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6/PI3K/AKT axis
Journal of Translational Medicine 2024cited by 11position: middledoi
The comprehensive relationship between combined anti-inflammatory and healthy diets and all-cause mortality in rheumatoid arthritis: results from NHANES 2003–2018
Arthritis Research & Therapy 2024cited by 5position: middledoi
Advancements and applications of single-cell multi-omics techniques in cancer research: Unveiling heterogeneity and paving the way for precision therapeutics
Biochemistry and Biophysics Reports 2023cited by 44position: middledoi
Resolvin D2 Reduces Chronic Neuropathic Pain and Bone Cancer Pain via Spinal Inhibition of IL-17 Secretion, CXCL1 Release and Astrocyte Activation in Mice
Brain Sciences 2023cited by 17position: middledoi
Involvement of RUVBL1 in WNT/β-Catenin Signaling in Oral Squamous Cell Carcinoma
Disease Markers 2022cited by 12position: middledoi
Interaction of FOXO1 and SUMOylated PPARγ1 induced by hyperlipidemia and hyperglycemia favors vascular endothelial insulin resistance and dysfunction
Vascular Pharmacology 2022cited by 11position: firstdoi
Effects of high-fat diet on thyroid autoimmunity in the female rat
BMC Endocrine Disorders 2022cited by 7position: middledoi
Population pharmacokinetic analysis and dosing guidelines for tacrolimus co‐administration with Wuzhi capsule in Chinese renal transplant recipients
Journal of Clinical Pharmacy and Therapeutics 2021cited by 34position: middledoi
Machine learning‐based method for tacrolimus dose predictions in Chinese kidney transplant perioperative patients
Journal of Clinical Pharmacy and Therapeutics 2021cited by 20position: middledoi
Trans‐repression of<scp>NF</scp>κB pathway mediated by<scp>PPAR</scp>γ improves vascular endothelium insulin resistance
Journal of Cellular and Molecular Medicine 2018cited by 13position: firstdoi
tRF/miR-1280 Suppresses Stem Cell–like Cells and Metastasis in Colorectal Cancer
Cancer Research 2017cited by 340position: middledoi
Pharmacological activation of PPAR gamma ameliorates vascular endothelial insulin resistance via a non-canonical PPAR gamma-dependent nuclear factor-kappa B trans-repression pathway
European Journal of Pharmacology 2015cited by 34position: middledoi
Osteopontin-induced brown adipogenesis from white preadipocytes through a PI3K-AKT dependent signaling
Biochemical and Biophysical Research Communications 2015cited by 31position: middledoi
Cthrc1 overexpression is an independent prognostic marker in gastric cancer
Human Pathology 2014cited by 41position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Qiren Huang · Nanchang University4 papers (2015–2022)Guoqiang Yan · Nanchang University3 papers (2015–2025)Xiaohua Wei · Nanchang University3 papers (2021–2025)Zhengzheng Liao · Nanchang University2 papers (2022–2025)Qun Fu · Nanchang University2 papers (2021–2021)Meiqi Liu · Nanchang University2 papers (2015–2018)Jia-Jia Chu · Nanchang University2 papers (2015–2015)Ri-Xin Zhan · Nanchang University2 papers (2015–2018)Ming He · Hangzhou Red Cross Hospital2 papers (2015–2015) · 2 papers (2021–2021)Guohua Zeng · Nanchang University2 papers (2018–2022)Zesong Li · Jilin University2 papers (2017–2023)Xiao-Juan Zhong · Nanchang University2 papers (2015–2015)Hongwei Peng · Nanchang University2 papers (2021–2021)Wanwan Yuan · Nanchang University2 papers (2022–2025)Ying Zhang · Nanchang University2 papers (2015–2018)Hong Liu · Prevention Institute2 papers (2021–2021)Teng Li · Nanchang University2 papers (2015–2015)Li Yu · King Center1 papers (2024–2024)Chao Wang · China Agricultural University1 papers (2025–2025)